Abstract
The fibrinogen clotting time (FCT) is a measure of thrombin activity, and is used to evaluate the potential thrombogenicity of prothrombin complex concentrates (PCC). We have defined end points for clot formation in this test which allow the measurement in PCC of thrombin concentrations as low as 0.001 IU/ml. The FCT of thrombin and PCC samples which did not contain antithrombin III (ATIII) were the same when measured at 20 degrees C or 37 degrees C. In the presence of ATIII (0.05 or 0.25 IU/ml), samples of PCC which were known to contain thrombin showed shorter FCT at 20 degrees C than at 37 degrees C. Inclusion of both ATIII (0.25 IU/ml) and heparin (4 IU/ml) in PCC ensured the complete inactivation of endogenous thrombin.
MeSH terms
-
Antithrombin III / metabolism
-
Benzamidines / pharmacology
-
Blood Coagulation / drug effects
-
Blood Coagulation Factors / adverse effects
-
Blood Coagulation Factors / chemistry
-
Blood Coagulation Factors / standards*
-
Blood Coagulation Tests*
-
Fibrinogen / metabolism*
-
Heparin / pharmacology
-
Hirudins / pharmacology
-
Humans
-
Phenylalanine / analogs & derivatives
-
Phenylalanine / pharmacology
-
Piperidines / pharmacology
-
Reproducibility of Results
-
Temperature
-
Thrombin / analysis*
-
Thrombin / metabolism
-
Thrombosis / etiology
-
Thrombosis / prevention & control*
Substances
-
Benzamidines
-
Blood Coagulation Factors
-
Hirudins
-
Piperidines
-
prothrombin complex concentrates
-
Phenylalanine
-
Antithrombin III
-
Fibrinogen
-
Heparin
-
N-dansyl-(1,4-guanidino)phenylalanine piperdide
-
Thrombin
-
benzamidine